 96 (40.0 %), 144 (60.0 %), 164 (68.3 %) et 104 (43.3 %) respectivement. Dyslipidaemia s'est produit dans 56 (58.3 %) 
INTRODUCTION
Concentration of glycated haemoglobin (HbA 1C ) is an indicator of average blood glucose concentration over the preceeding two-three months. HbA 1C is currently considered the best index of glycaemic control for diabetic patients in clinical settings. 1, 2 . HbA 1C is used both as an index of mean glycaemia and as a measure of risk for the development of micro-and macrovascular diabetic complications. 3, 4 Studies suggest that poor glycaemic control is significantly associated with the development of macrovascular complications of diabetes mellitus. 3 Other studies also indicate that dyslipidaemia, that is, abnormal levels of lipids, is an important risk factor for cardiovascular disease. 5 Similarly, the metabolic syndrome is a "clustering" of several risk factors for cardiovascular disease and early mortality in patients with type 2 diabetes 6 and nondiabetic subjects. 7 Thus, poor glycaemic control (HbA 1C ), dyslipidaemia and metabolic syndrome are all risk factors for cardiovascular disease.
An association between HbA 1C , dyslipidaemia and metabolic syndrome, the commonly measured indicators of cardiovascular disease has not been determined among diabetes mellitus patients in the Northern Region of Ghana. Thus the objective of this study was to investigate the relative prevalence of poor glycaemic control, dyslipidaemia and metabolic syndrome and a possible association between poor glycaemic control, dyslipidaemia and metabolic syndrome among recently diagnosed diabetes mellitus patients in the Northern Region of Ghana.
SUBJECTS, MATERIALS, AND METHODS

Study Population
This prospective study was conducted at the Tamale Teaching/ Regional Hospital in the Northern Region of Ghana from September 2006 to August 2007. All participants consented to participate in the research. Study protocols were approved by the ethics committee of the hospital. Recently diagnosed (<1 year) diabetes mellitus patients were consecutively selected until a sample size of 240 was obtained. Diabetes was defined according to the WHO. 8 Patient's file values of the same day of data collection were used as an aid to cross check, and where necessary interviews and measurements were repeated.
Data Collection
A standardized questionnaire was used to collect information on demographic and clinical characteristics such as age, sex, ethnicity (tribe) duration of diabetes, family history of diabetes, hypertension, other physician-diagnosed diseases and stress, and diabetes and hypertension medication profile.
Physical Measurements
Heights and weights were measured in subjects wearing lightweight clothing and without shoes and BMI calculated (kg/m 2 ). Waist circumference was measured on bare skin during midrespiration at the narrowest indentation midway between the lowest rib and the iliac crest. 6, 9, 10 Blood pressure was measured twice per patient with five minutes intervals in the sitting position after 30 minutes of rest and the mean recorded.
Biochemical Measurements
Blood specimens were obtained after eight to fourteen hours of overnight fast. Serum fasting glucose, total cholesterol, triglycerides, and high density lipoprotein (HDL) cholesterol were measured by enzymatic methods using an ATAC 8,000 Random Access Chemistry autoanalyzer (élan diagnostics, A4-001-1198) and its reagent kits. LDL cholesterol was calculated using Friedewald's formula. 11 
Statitical Analyses
Statistical analyses were performed using the statistical package for social sciences (SPSS) for windows programme version 11.0. The χ 2 test was used to determine the statistical significance of differences in proportions. A p value of less than 0.05 was considered significant.
RESULTS
A total of 240 recently diagnosed (<1 year) diabetes mellitus patients were recruited into this study, with 59 (24. 14 This value also indicates that 68.3% of the patients carry cardiovascular risk by total dyslipidaemic prevalence values.
The prevalence of dyslipidaemia in patients with poor glycaemic control (75.0%) was significantly higher than that in patients with good glycaemic control (58.3%). Thus dyslipidaemia was associated with worsening glycaemic control. This agrees with earlier findings that indicated that dyslipidaemia was positively associated with HbA 1C in individuals with diabetes. 15 The prevalence of the metabolic syndrome among the recently diagnosed diabetes patients was 43.3%. This value is lower than the value of 68.5% found among diabetes patients in the Republic of Cyprus using the NCEP ATP III criteria (used in this study). This also implies that 43.3% of the patients had risk for cardiovascular disease by metabolic syndrome prevalence value. The prevalence of the metabolic syndrome in patients with poor glycaemic control (50.0%) was significantly higher than that in patients with good glycaemic control (33.3%). Thus, the metabolic syndrome was associated with worsening glycaemic control. Dyslipidaemia (68.3%) was the most sensitive predictor of cardiovascular disease, followed by poor glycaemic control (60.0%), and thirdly metabolic syndrome (43.3%) in this study. However, whether dyslipidaemia was the most specific predictor of cardiovascular disease remains to be determined.
Conclusion
Dyslipidaemia and metabolic syndrome are each associated with poor glycaemic control (HbA 1C >7.5%) in Northern Ghanaian diabetics. Poor glycaemic control, dyslipidaemia and metabolic syndrome may be independent risk factors for cardiovascular disease. Hence, poor glycaemic control can neither replace dyslipidaemia nor metabolic syndrome as an indicator of cardiovascular disease. Dyslipidaemia was the most sensitive predictor of cardiovascular disease, followed by poor glycaemic control and thirdly metabolic syndrome.
hundred and four (43.3%) of the recently diagnosed diabetic patients had metabolic syndrome. It was observed that 32 (33.3%) of the patients with good glycaemic control had metabolic syndrome (Table 2 ) and 72 (50.0%) of the patients with poor glycaemic control had metabolic syndrome.
DISCUSSION
Cardiovascular disease is the leading cause of death in type 2 diabetes. 13 Poor glycaemic control, dyslipidaemia and metabolic syndrome are all risk factors for cardiovascular disease. 3, 5, 6 
